New Platform Coming Soon. AI based analysis with Human Generated Insights.

Search Blog

Contribute to our Blog

Tag: Alnylam Pharmaceuticals’ price target

Alnylam Pharmaceuticals’ (ALNY:NSD) Patisiran Gains FDA Panel Approval for Treating Cardiomyopathy

Get our Premium Service free for -days!

Link watchlist to your brokerage
Premium Newsletter
Daily Analyst Ratings
Detailed Stock Analysis
Top Picks
Watchlists and Portfolios
Advanced Screens
Detailed Reports
Donwloadable Data

Join over half-million smart investors across the world

Select Market

I agree to Stock Target Adivsor Terms and Conditions

or Sign up with